Kura Oncology (KURA) Amortizatization of Intangibles (2015 - 2026)
Kura Oncology (KURA) reported Amortizatization of Intangibles of $900000.0 for Q1 2026, down 66.19% year-over-year from $2.7 million in Q1 2025, and down 34.88% on a QoQ basis from $1.4 million in Q4 2025.
Kura Oncology (KURA) has 12 years of Amortizatization of Intangibles data on file, last reported at $900000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles fell 66.19% year-over-year to $900000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (down 46.33% YoY) and the FY2025 annual result came in at $8.5 million, down 35.41% from the prior year.
- Amortizatization of Intangibles eased to $900000.0 in Q1 2026 per KURA's latest filing, from $1.4 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $3.5 million in Q2 2024 and bottomed at -$1.1 million in Q1 2022.
- The 5-year median for Amortizatization of Intangibles is $2.1 million (2023), against an average of $1.8 million.
- The widest annual swing landed in 2023, when Amortizatization of Intangibles surged 881.08%; it then plunged 66.19% in 2026.
- Tracing KURA's Amortizatization of Intangibles over 5 years: stood at $654000.0 in 2022, then jumped by 317.89% to $2.7 million in 2023, then advanced by 5.56% to $2.9 million in 2024, then sank by 52.1% to $1.4 million in 2025, then slumped by 34.88% to $900000.0 in 2026.
- Per Business Quant, the three latest KURA Amortizatization of Intangibles figures stand at $900000.0 (Q1 2026), $1.4 million (Q4 2025), and $1.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn | 900,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 900,000.00 |
| Mar 31, 2026 | 900,000.00 |
| Dec 31, 2025 | 1.38 Mn |
| Dec 31, 2025 | 1.38 Mn |
| Sep 30, 2025 | 1.92 Mn |
| Sep 30, 2025 | 1.92 Mn |
| Jun 30, 2025 | 2.52 Mn |
| Jun 30, 2025 | 2.52 Mn |
| Mar 31, 2025 | 2.66 Mn |
| Mar 31, 2025 | 2.66 Mn |
| Dec 31, 2024 | 2.89 Mn |
| Dec 31, 2024 | 2.89 Mn |
| Sep 30, 2024 | 3.44 Mn |
| Sep 30, 2024 | 3.44 Mn |
| Jun 30, 2024 | 3.55 Mn |
| Jun 30, 2024 | 3.55 Mn |
| Mar 31, 2024 | 3.27 Mn |
| Mar 31, 2024 | 3.27 Mn |
| Dec 31, 2023 | 2.73 Mn |
| Dec 31, 2023 | 2.73 Mn |
| Sep 30, 2023 | 2.89 Mn |
| Sep 30, 2023 | 2.89 Mn |
| Jun 30, 2023 | 2.11 Mn |
| Jun 30, 2023 | 2.11 Mn |
| Mar 31, 2023 | 1.69 Mn |
| Mar 31, 2023 | 1.69 Mn |
| Dec 31, 2022 | 654,000.00 |
| Dec 31, 2022 | 654,000.00 |
| Sep 30, 2022 | -370,000.00 |
| Sep 30, 2022 | -370,000.00 |
| Jun 30, 2022 | -794,000.00 |
| Jun 30, 2022 | -794,000.00 |
| Mar 31, 2022 | -1.10 Mn |
| Mar 31, 2022 | -1.10 Mn |
| Dec 31, 2021 | -1.22 Mn |
| Dec 31, 2021 | -1.22 Mn |
| Sep 30, 2021 | -1.19 Mn |
| Sep 30, 2021 | -1.19 Mn |
| Jun 30, 2021 | -1.14 Mn |
| Jun 30, 2021 | -1.14 Mn |
| Mar 31, 2021 | -850,000.00 |
| Mar 31, 2021 | -850,000.00 |
| Dec 31, 2020 | -368,000.00 |
| Dec 31, 2020 | -368,000.00 |
| Sep 30, 2020 | -176,000.00 |
| Sep 30, 2020 | -176,000.00 |
| Jun 30, 2020 | 24,000.00 |
| Jun 30, 2020 | 24,000.00 |
| Mar 31, 2020 | 110,000.00 |
| Mar 31, 2020 | 110,000.00 |
| Dec 31, 2019 | 116,000.00 |
| Dec 31, 2019 | 116,000.00 |
| Sep 30, 2019 | 128,000.00 |
| Sep 30, 2019 | 128,000.00 |
| Jun 30, 2019 | 319,000.00 |
| Jun 30, 2019 | 319,000.00 |
| Mar 31, 2019 | 540,000.00 |
| Mar 31, 2019 | 540,000.00 |
| Dec 31, 2018 | 636,000.00 |
| Dec 31, 2018 | 636,000.00 |
| Sep 30, 2018 | 596,000.00 |
| Sep 30, 2018 | 596,000.00 |
| Jun 30, 2018 | 428,000.00 |
| Jun 30, 2018 | 428,000.00 |
| Mar 31, 2018 | 275,000.00 |
| Mar 31, 2018 | 275,000.00 |
| Dec 31, 2017 | 187,000.00 |
| Dec 31, 2017 | 187,000.00 |
| Sep 30, 2017 | 76,000.00 |
| Sep 30, 2017 | 76,000.00 |
| Jun 30, 2017 | -22,000.00 |
| Jun 30, 2017 | -22,000.00 |
| Mar 31, 2017 | 19,000.00 |
| Mar 31, 2017 | 19,000.00 |
| Dec 31, 2016 | -10,000.00 |
| Dec 31, 2016 | -10,000.00 |
| Sep 30, 2016 | -16,000.00 |
| Sep 30, 2016 | -16,000.00 |
| Jun 30, 2016 | -38,000.00 |
| Jun 30, 2016 | -38,000.00 |
| Mar 31, 2016 | -65,000.00 |
| Mar 31, 2016 | -65,000.00 |
| Dec 31, 2015 | -67,000.00 |
| Dec 31, 2015 | -67,000.00 |
| Sep 30, 2015 | -67,000.00 |
| Sep 30, 2015 | -67,000.00 |